BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 14689211)

  • 1. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous regression of localized neuroblastoma detected by mass screening.
    Yamamoto K; Hanada R; Kikuchi A; Ichikawa M; Aihara T; Oguma E; Moritani T; Shimanuki Y; Tanimura M; Hayashi Y
    J Clin Oncol; 1998 Apr; 16(4):1265-9. PubMed ID: 9552024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
    Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
    J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
    Tanaka M; Kigasawa H; Kato K; Ijiri R; Nishihira H; Aida N; Ohama Y; Tanaka Y
    Pediatr Blood Cancer; 2010 Apr; 54(4):573-8. PubMed ID: 20049932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
    Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
    J Pediatr Surg; 1990 Apr; 25(4):398-401. PubMed ID: 2329455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
    Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
    Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma.
    Hirata T; Tatara H; Zaizen Y; Suita S; Matsuzaki A; Ueda K
    J Clin Ultrasound; 1995 Jun; 23(5):305-13. PubMed ID: 7642769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening.
    Fritsch P; Kerbl R; Lackner H; Urban C
    Pediatr Blood Cancer; 2004 Nov; 43(6):679-82. PubMed ID: 15390301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete resection is not required in patients with neuroblastoma under 1 year of age.
    Kaneko M; Iwakawa M; Ikebukuro K; Ohkawa H
    J Pediatr Surg; 1998 Nov; 33(11):1690-4. PubMed ID: 9856897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial measurement of urinary VMA and HVA levels from one infant: a study for neuroblastoma mass screening.
    Sawada T; Numata K; Hirata S
    J Pediatr Surg; 1992 Apr; 27(4):452-5. PubMed ID: 1522454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Yamashiro K; Takasugi N; Hanai J; Kawai T
    Eur J Pediatr; 1990 Sep; 149(12):859-61. PubMed ID: 2226572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.